Pharmexa A/S is a biotechnology company that specializes in the development of therapeutic vaccines for the treatment of cancer and infectious diseases. The company's innovative approach to vaccine design has led to the development of several promising candidates currently in pre-clinical and clinical trials. With a focus on personalized medicine and precision targeting, Pharmexa aims to revolutionize the field of immunotherapy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#9 in Hørsholm

#328 in Denmark

Hørsholm, Denmark

Pharmexa A/s

Forward Citations = 114

15 inventors:

Steen Klysner (4 out of 4 patents)

Søren Mouritsen (3 out of 5 patents)

Klaus Gregorius Nielsen (3 out of 9 patents)

4. Martin Roland Jensen (2 out of 4 patents)

5. Peter Birk Rasmussen (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmexa A/s. Retrieved from https://idiyas.com/company/pharmexa-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]